Forster Céline, Chriqui Louis-Emmanuel, Abdelnour-Berchtold Etienne, Zellweger Matthieu, Perentes Jean Yannis, Krueger Thorsten, Gonzalez Michel
Department of Thoracic Surgery, Centre Hospitalier du Valais Romand (CHVR), Sion, Switzerland.
Department of Thoracic Surgery, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Thorac Cancer. 2025 Jun;16(12):e70116. doi: 10.1111/1759-7714.70116.
Repeated anatomical pulmonary resections in second primary nonsmall-cell lung cancer (NSCLC) pose significant challenges due to prior surgery. This study evaluates the feasibility and short-term outcomes of repeated anatomical pulmonary resections for second primary NSCLC.
We retrospectively reviewed all consecutive cases of repeated anatomical pulmonary resections for second primary NSCLC performed in our institution from January 2014 to December 2023.
A total of 55 patients (median age 68 years; interquartile range [IQR]: 61.5-72) underwent repeated anatomical pulmonary resections for second primary NSCLC. Adenocarcinoma predominated in both primary (78.2%) and secondary (76.4%) cases. Video-assisted thoracoscopy (VATS) approach was used in 94.5% and 96.4% for first and repeated resection, respectively (p = 0.647). The extent of pulmonary resection differed between first and repeated resection, with a predominance of lobectomy during first resection (56.4%) and segmentectomy during repeated resection (85.5%, p < 0.001). We did not observe any significant difference in postoperative overall morbidity after first and repeated resection (23.6% vs. 40%, p = 0.065). However, there was an increased incidence of atrial fibrillation (16.4% vs. 0%) and prolonged air leak (> 5 days) after repeated resection (25.5% vs. 5.5%, p = 0.008). The median length of hospital stay was similar after first and repeated resection (5 vs. 5 days, p = 0.089). The three-year overall survival (OS) was 73% after first resection and 87% after repeated resection. Overall disease recurrence rate was not statistically different between first and repeated resection (1.8% vs. 3.6%, p = 0.558).
Our series demonstrated that second primary NSCLC can be safely managed by VATS segmentectomy, yielding favorable short-term survival and low recurrence rates.
由于既往手术史,对第二原发性非小细胞肺癌(NSCLC)进行重复的解剖性肺切除术面临重大挑战。本研究评估了对第二原发性NSCLC进行重复解剖性肺切除术的可行性和短期结果。
我们回顾性分析了2014年1月至2023年12月在我院进行的所有连续性第二原发性NSCLC重复解剖性肺切除术病例。
共有55例患者(中位年龄68岁;四分位间距[IQR]:61.5 - 72)接受了第二原发性NSCLC的重复解剖性肺切除术。腺癌在原发性(78.2%)和继发性(76.4%)病例中均占主导。首次和重复切除分别有94.5%和96.4%采用了电视辅助胸腔镜手术(VATS)入路(p = 0.647)。首次和重复切除的肺切除范围不同,首次切除以肺叶切除术为主(56.4%),重复切除以肺段切除术为主(85.5%,p < 0.001)。我们未观察到首次和重复切除术后总体并发症发生率有任何显著差异(23.6%对40%,p = 0.065)。然而,重复切除后房颤发生率增加(16.4%对0%),漏气时间延长(> 5天)(25.5%对5.5%,p = 0.008)。首次和重复切除后的中位住院时间相似(5天对5天,p = 0.089)。首次切除后三年总生存率(OS)为 73%,重复切除后为87%。首次和重复切除之间的总体疾病复发率无统计学差异(1.8%对3.6%,p = 0.558)。
我们的系列研究表明,第二原发性NSCLC可通过VATS肺段切除术安全治疗,短期生存率良好且复发率低。